Alkurin (1500 mg+250 mg)/5 ml (Oral Solution)
Medicine Details
Category | Details |
---|---|
Generic | Potassium citrate citric acid |
Company | Ibn sina pharmaceuticals ltd |
Indications
- To relieve discomfort in urinary tract infections
- To prevent kidney stone
- With uricosuric agent to prevent gout
- Acidosis caused by kidney diseases
Pharmacology
Potassium Citrate and Citric Acid oral solution is a stable and pleasant-tasting oral systemic alkalizer. It alkalinizes the urine without producing a systemic alkalosis. Highly palatable and tolerable for long-term use. Does not neutralize the gastric juice or disturb digestion.
Dosage & Administration
- Relieve discomfort in UTI:
- Adults and children over 6 years: 10 ml 3 times daily, diluted with 1 glass of water
- Children 1-6 years: 5 ml 3 times daily, diluted with ½ glass of water
- Prevent kidney stones, Gout prevention, Acidosis caused by kidney diseases:
- Adults: 10-15 ml 4 times daily (or as directed by the physician) diluted with 1 glass of water
- Pediatric: 5-10 ml 4 times daily (or as directed by the physician) diluted with ½ glass of water
Interaction
Concurrent administration of potassium-containing medication, potassium-sparing diuretics, ACE inhibitors or cardiac glycosides may lead to toxicity.
Contraindications
Severe renal impairment with oliguria or azotemia, untreated Addison's disease, acute dehydration, severe myocardial damage, hyperkalemia from any cause
Side Effects
Generally well tolerated, caution in certain patients with abnormal renal mechanisms to avoid hyperkalemia or alkalosis. Listlessness, weakness, mental confusion, tingling of extremities with potassium intoxication
Pregnancy & Lactation
No information available regarding use during pregnancy and lactation
Precautions & Warnings
Use with caution in patients with low urinary output, dilute with water to avoid gastrointestinal injury, preferably take after meals. Large doses may cause hyperkalemia and alkalosis, especially with renal disease
Overdose Effects
Rarely causes serious hyperkalemia in persons with normal excretory mechanisms for potassium. If impaired, hyperkalemia can result and must be treated immediately to avoid lethal levels.
Therapeutic Class
- Prevention of repeated kidney stone formation
- Urinary Alkalinizing Agent
Storage Conditions
Keep below 30°C, away from light & moisture, out of the reach of children
Related Brands
- Citra-K (1500 mg+250 mg)/5 ml (Oral Solution) - unimed-unihealth-pharmaceuticals-ltd
- Urikal (1500 mg+250 mg)/5 ml (Oral Solution) - incepta-pharmaceuticals-ltd
- Urinor (1500 mg+250 mg)/5 ml (Oral Solution) - novelta-bestway-pharma-ltd
- Uriset (1500 mg+250 mg)/5 ml (Oral Solution) - square-pharmaceuticals-plc
- Urokit Plus (1500 mg+250 mg)/5 ml (Oral Solution) - eskayef-pharmaceuticals-ltd